Clinical Trials Logo

Clinical Trial Summary

Roux-en-Y gastric bypass (RYGB) accelerates nutrient delivery to the small intestine causing higher peak blood glucose concentration early after meal intake. In the late postprandial period (1 1⁄2-2 h) nadir blood glucose level is lower compared with before operation. In some patients, overt postprandial hypoglycaemia develops, and is typically reported as a complication 1-5 years postoperatively, when maximal weight loss has been obtained. The pathophysiology of postprandial hypoglycaemia involves inappropriate hyper-secretion of insulin associated with exaggerated secretion of the gut hormone glucagon-like peptide-1 (GLP-1) leading to a mismatch between glucose absorption rate, insulin secretion and whole body glucose disposal. We hypothesize that lowering carbohydrate content of meals reduces postprandial glucose excursions whereby GLP-1 and insulin secretion is reduced and reactive hypoglycemia prevented.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT02665715
Study type Interventional
Source Bispebjerg Hospital
Contact
Status Completed
Phase N/A
Start date August 2015
Completion date June 2016

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02374632 - Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass Phase 4
Active, not recruiting NCT02372526 - The Effect of Different Macronutrients on Gastrointestinal Hormone Secretion After Gastric Bypass Operation N/A